Nucleate Podcast
de Nucleate
Cel mai nou episod
Investing in the Radical: with Amino Collective VC | Nirmesh Patel
Investing in the Radical: with Amino Collective VC | Nirmesh Patel
Despre acest podcast
Nucleate is the new voice for next generation biotech leaders.
Episoade
Cele mai noi 20 din 55 episoade
- Investing in the Radical: with Amino Collective VC | Nirmesh Patel · 58 min · Episodul 56Nirmesh Patel describes his path from biomedical research at King’s College and a PhD focused on triple-negative breast cancer to founding CCG AI. He founded the company while…
- Trailblazing Tough Tech | Ann DeWitt · 50 min · Episodul 55In this episode we welcome Ann DeWitt, General Partner at Engine Ventures. She introduces Engine Ventures and how it grew out of MIT to back tough tech companies that work across…
- From PlayStation to Psychedelics: A Brain Health VC's Pivot | Matias Serebrinsky · 53 min · Episodul 54The Nucleate Podcast welcomes Matias Serebrinsky, co-founder of Psymed Ventures. Raised in Argentina by a physician father and an economist mother, he shares how his early life…
- The Founder’s Playbook: Pitching, Pivoting, and De-risking Early-Stage Science | Dr. Jo Viney · 1 h 17 min · Episodul 53In this episode of the Nucleate Podcast, Dr. Jo Viney, co-founder, president, and CEO of Seismic Therapeutic, shares her trajectory from academic immunology training in London to…
- AI, Amino Acids, and Aging: Inside Retro Biosciences | Joe Betts-Lacroix · 56 min · Episodul 52In this episode of the Nucleate Podcast, Joe Betts-LaCroix, co-founder of Retro Biosciences, traces his path from Silicon Valley hardware startups to longevity biotech…
- Building, Breaking, and Rebuilding Biotech | Deborah Dunsire · 1 h 47 min · Episodul 51She started out as a small-town GP in South Africa with zero idea a "biotech industry" even existed. Three decades later, Deborah Dunsire had led the launch of Gleevec — the…
- From Nobel-Winning Discovery to Co-Founding Biogen | Phil Sharp · 1 h 30 min · Episodul 50In this episode of the podcast we are joined by Dr. Phillip Sharp, Nobel Prize Laureate and Institute Professor at MIT, who shares his story behind the groundbreaking discovery…
- Zero to One: The Precision Medicine Playbook for Cardiac Disease | Nolan Townsend Lexeo Therapeutics · 58 min · Episodul 49This episode of the Nucleate Podcast features host Sam Kessler in conversation with Nolan Townsend, CEO of Lexeo Therapeutics, a New York-based clinical-stage biotech developing…
- Refusing to give up on an Oncology Breakthrough | Dana T. Aftab, Exelixis · 1 h 23 min · Episodul 48In this episode of the Nucleate Podcast, Dana Aftab, Executive Vice President, R&D at Exelixis, shares his journey to becoming a leader in drug discovery and what he’s learned…
- Using Philanthropy to Drive Cures for Multiple Myeloma | Stephanie Oestreich, PhD MMRF · 1 h 6 min · Episodul 47In this episode, we welcome Stephanie Oestreich, Managing Director at the Multiple Myeloma Research Foundation. She holds a PhD in biochemistry from Harvard Medical School and an…
- Translating Science into Patient Impact with Kendra Rose · 1 h 3 min · Episodul 46In this episode we are joined by Kendra Rose, Senior Vice President of BD&L at Bayer, who brings a blend of scientific depth and business acumen to the conversation. Her journey…
- Leading Mission-Driven Biotechs | Jodie Morrison, CEO of Q32 Bio · 1 h 6 min · Episodul 45In this episode of the Nucleate podcast, Jodie Morrison, CEO of Q32 Bio, discusses her extensive career path from clinical research to executive leadership. She explains her…
- From Genomics to Deal-Making: How Science Becomes a Company | Laurence Reid, Biotech Entrepreneur · 1 h 36 min · Episodul 44In this episode, we sit down with Laurence Reid, former CEO of Decibel Therapeutics and Warp Drive Bio, former Chief Business Officer at Alnylam, and one of biotech’s most…
- Negotiating Intellectual Property, Staying Focused, and Making the Most of Mentors with Michal Preminger, Board Member at MassBio · 1 h 7 min · Episodul 43In this episode of the podcast we are joined by Michal Preminger, Board Member at MassBio, who shares her remarkable journey spanning across academia, biotech, and global…
- How Turbine Accelerates Drug Discovery with AI Simulation | Szabi Nagy, CEO and Co-Founder of Turbine · 57 min · Episodul 42In this episode we are joined by Szabi Nagy, CEO and Co-Founder of Turbine. He shares his first startup experience, and how the lessons he learned there helped shape his work at…
- The Science of Stem Cells and Social Impact: Inside Ovelle with Merrick Smela and Travis Potter · 50 min · Episodul 41Merrick Smela, Chief Scientific Officer, and Travis Potter, Chief Executive Officer of Ovelle, joined the Nucleate Podcast to discuss their mission to revolutionize infertility…
- Inside TechBio Investing | Claire Smith, Partner at Springtide VC · 1 h 3 min · Episodul 40In this episode of the podcast we sit down with Claire Smith, Partner at SpringTide. She reflects on her journey from a biological engineering student at MIT to her current role…
- Functional Precision Oncology, a new compass for cancer care | Apricot Bio · 1 h 23 min · Episodul 39In this special panel episode recorded in Zurich, the founders of Apricot Bio, Michael Zering (CEO), Lucas Pelkmans (Scientific Founder), and Independent Professor Andreas Wicki…
- The Art and Science of Drug Hunting | Christoph Lengauer, CSO & Co-Founder of Curie.bio · 1 h 12 min · Episodul 38In this episode, we sit down with Christoph Lengauer, co-founder of Curie.Bio, a venture creation firm, and former founding CSO and Chief Drug Hunter at Blueprint Medicines…
- Blackjack, Biosecurity and Big Bets | Alexander Titus, National Biotech Commissioner · 1 h 7 min · Episodul 37In this episode, we sit down with Alexander Titus—computational biologist, founder of the In Vivo Group, Head of AI at Avidity Biosciences, and commissioner on the National…
